Michael Barbella, Managing Editor04.01.22
AccurKardia Inc. and MDF Instruments are teaming up against the world's most deadly disease.
The pair is partnering to develop electrocardiogram (ECG) solutions for the next generation of stethoscopes in an effort to reduce cardiovascular disease deaths. “We are excited to partner with AccurKardia, an innovator in the ECG analytics domain, to define and implement new tools to empower clinicians at all stages of patient management to identify disease at its infancy,” said Darren Ting, CEO of MDF Instruments.
The collaboration brings together AccurKardia’s innovation in device-agnostic, automated ECG analytics with clinical-grade accuracy and MDF Instruments’ more than 40 years of experience designing, manufacturing, and distributing premium diagnostic instruments.
Cardiovascular disease is the leading cause of death globally, accounting for approximately 18.6 million deaths in 2019.1 Early detection is critical and could mean the difference between life and death for thousands of at-risk patients. Together, AccurKardia and MDF Instruments will empower and equip physicians and healthcare workers with state-of-the-art, evidence-based ECG real-time analysis at the point of care.
“We are honored to partner with MDF instruments, a leader in diagnostic instruments, with an understanding of the needs of healthcare professionals. Our companies share the goal of improving patient outcomes," said Juan C. Jiménez, CEO of AccurKardia. “By enabling the next generation of stethoscopes with automated ECG analysis capabilities, early and actionable insight for intervention and treatment can be provided, and that will help save lives.”
AccurKardia is a digital-first and software-only healthcare company that provides clinical-grade, device-agnostic, API-accessible automated ECG analytics to clinical and consumer-grade ECG devices, as well as telehealth and remote patient monitoring companies.
MDF Instruments has been crafting stethoscopes, and medical diagnostic instruments since 1971.
Reference
1 Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., et al. … American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee (2021). Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation, 143(8), e254–e743. https://doi.org/10.1161/CIR.0000000000000950
The pair is partnering to develop electrocardiogram (ECG) solutions for the next generation of stethoscopes in an effort to reduce cardiovascular disease deaths. “We are excited to partner with AccurKardia, an innovator in the ECG analytics domain, to define and implement new tools to empower clinicians at all stages of patient management to identify disease at its infancy,” said Darren Ting, CEO of MDF Instruments.
The collaboration brings together AccurKardia’s innovation in device-agnostic, automated ECG analytics with clinical-grade accuracy and MDF Instruments’ more than 40 years of experience designing, manufacturing, and distributing premium diagnostic instruments.
Cardiovascular disease is the leading cause of death globally, accounting for approximately 18.6 million deaths in 2019.1 Early detection is critical and could mean the difference between life and death for thousands of at-risk patients. Together, AccurKardia and MDF Instruments will empower and equip physicians and healthcare workers with state-of-the-art, evidence-based ECG real-time analysis at the point of care.
“We are honored to partner with MDF instruments, a leader in diagnostic instruments, with an understanding of the needs of healthcare professionals. Our companies share the goal of improving patient outcomes," said Juan C. Jiménez, CEO of AccurKardia. “By enabling the next generation of stethoscopes with automated ECG analysis capabilities, early and actionable insight for intervention and treatment can be provided, and that will help save lives.”
AccurKardia is a digital-first and software-only healthcare company that provides clinical-grade, device-agnostic, API-accessible automated ECG analytics to clinical and consumer-grade ECG devices, as well as telehealth and remote patient monitoring companies.
MDF Instruments has been crafting stethoscopes, and medical diagnostic instruments since 1971.
Reference
1 Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., et al. … American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee (2021). Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation, 143(8), e254–e743. https://doi.org/10.1161/CIR.0000000000000950